Recognize how pharmacists can contribute to opioid deprescribing and inappropriate pain relief Moderator: - Parisa Aslani, Co-chair of the working group on Patient Safety, University of Sydney, Australia Panellists: - Paul Glare, Chair of Pain Medicine and Director of the Pain Management Research Institute (PMRI) Northern Clinical School, School of Medicine, Faculty of Medicine & Health, University of Sydney, Australia - Jonathan Penm, Assistant Secretary, Hospital Pharmacy Section FIP, Australia - Sri Suryawati, Head, Division of Clinical Pharmacology and Medicine Policy, Department of Pharmacology and Therapeutics, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University
Made with Care Manufactured in a facility that meets current Good Manufacturing Practices (cGMP).
Image Credit: Ivanko / Shutterstock.com Supplements and nutraceuticals Nutraceuticals that influence incretin pathways may offer complementary benefits to lifestyle modification and pharmacotherapy
In the interventional LISA study (NCT00463489), which tested telephone-based lifestyle counseling, participants who received the behavioral intervention had a mean weight loss of 5.5% at 12 months
Russell, et al
